Daily NSE closing prices — this stock isn't in the live-tracked universe yet.
NSE Close — 19 Nov 2026
₹170.99
Change
+0.98 (0.58%)
Open
₹170.2
Prev. Close
₹170.01
Day High
₹172.9
Day Low
₹170.2
Volume Analysis
Traded
12,323
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (0)
No signal for this stock
Weaknesses (1)
- •Promoter holding is falling
Opportunities (0)
No signal for this stock
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹175.22 | ₹174.06 | ₹172.52 | ₹171.36 | ₹169.82 | ₹168.66 | ₹167.12 |
| Fibonacci | ₹174.06 | ₹173.03 | ₹172.39 | ₹171.36 | ₹170.33 | ₹169.69 | ₹168.66 |
| Camarilla | ₹171.73 | ₹171.49 | ₹171.24 | ₹171.36 | ₹170.74 | ₹170.5 | ₹170.25 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
—
1 Week
-1.34%
1 Month
-0.24%
3 Months
+15.23%
6 Months
—
1 Year
—
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹79.72
Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
11.79%
Net margin 7.1% × asset turnover 0.81x × equity multiplier 2.05x
Company Overview
Sector
Healthcare
Market Cap
₹336 Cr
P/E (TTM)
31.3
ROE
10.4%
Book Value
₹53.9
Face Value
₹10.0
Source: Screener.in (Consolidated figures) — data as of 19 Nov 2026. Not investment advice.
TopFund Analysis
Qms Medical Allied S Ltd lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 55/100. The strongest factor is Risk & Volatility (81/100), while Liquidity (0/100) is the weakest area to weigh before deciding. Notably: Promoter holding is falling.
TopFund Score — Fundamentals Quality
55/100 — AverageData confidence: 75/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 19 Nov 2026 · How we calculate this →
Financial Strength
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- +Company has been maintaining a healthy dividend payout of 56.4%
- −Stock is trading at 3.23 times its book value
- −Company has a low return on equity of 12.0% over last 3 years.
- −Promoter holding has decreased over last 3 years: -5.56%
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Q2 and H1 FY27 earnings conference call scheduled for 17 November 2026 at 11:30 AM IST.
Regulation 74(5) certificate confirms entire shareholding in demat form for quarter ended September 30, 2026.
QMS Medical Allied Services’ 9th AGM resolutions passed; final dividend of Re.0.50 per share approved.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Dec 2023 | Mar 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 35 | 32 | 37 | 44 | 45 | 47 | 45 | 37 | 44 | 57 |
| Expenses + | 30 | 28 | 30 | 37 | 38 | 40 | 38 | 31 | 39 | 49 |
| Operating Profit | 5 | 4 | 7 | 7 | 6 | 7 | 7 | 7 | 6 | 8 |
| OPM % | 13.73% | 12.23% | 19.46% | 15.82% | 14.29% | 14.06% | 15.48% | 18.12% | 13.33% | 14.61% |
| Other Income + | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 3 | 2 | 6 | 5 | 5 | 4 | 5 | 4 | 3 | 6 |
| Tax % | 25.76% | 29.68% | 25.27% | 30.24% | 23.24% | 29.62% | 26.24% | 25.7% | 29.21% | 28.65% |
| Net Profit + | 2 | 2 | 4 | 3 | 4 | 3 | 4 | 3 | 2 | 4 |
| EPS in Rs | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 2 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — |
| YoY Sales growth | — | — | — | 24 | 38 | — | 20 | -15 | 0 | 22 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|
| Sales + | 122 | 156 | 173 | 183 |
| Expenses + | 104 | 130 | 147 | 155 |
| Operating Profit | 18 | 25 | 26 | 28 |
| OPM % | 15.0% | 16.0% | 15.0% | 15.0% |
| Other Income + | 0 | 2 | 1 | 1 |
| Interest | 3 | 5 | 7 | 7 |
| Depreciation | 3 | 4 | 4 | 5 |
| Profit before tax | 12 | 19 | 16 | 17 |
| Tax % | 26.0% | 27.0% | 27.0% | — |
| Net Profit + | 9 | 14 | 12 | 13 |
| EPS in Rs | 5 | 7 | 5 | 6 |
| Dividend Payout % | 0.0% | 74.0% | 95.0% | — |
| Sales growth | — | 28 | 11 | 6 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Reserves | 61 | 72 | 85 |
| Borrowings + | 35 | 60 | 74 |
| Other Liabilities + | 22 | 40 | 34 |
| Total Liabilities | 135 | 190 | 213 |
| Fixed Assets + | 24 | 52 | 55 |
| CWIP | 2 | 3 | 3 |
| Investments | 2 | 3 | 5 |
| Other Assets + | 108 | 131 | 150 |
| Total Assets | 135 | 190 | 213 |
| Equity Capital | 18 | 18 | 19 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Cash from Operating Activity + | 1 | 19 | 19 |
| Cash from Investing Activity + | -3 | -45 | -20 |
| Cash from Financing Activity + | 0 | 27 | 1 |
| Net Cash Flow | -1 | 1 | 0 |
| Free Cash Flow | 1 | 19 | 19 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 26 | 97 | 93 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Dec 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 25.62% | 25.12% | 25.32% | 26.33% | 26.33% | 26.33% | 26.33% | 30.28% | 30.3% | 30.3% | 30.17% |
| Promoters | 73.67% | 73.67% | 73.67% | 73.67% | 73.67% | 73.67% | 73.67% | 68.11% | 68.11% | 68.11% | 68.11% |
| FII | 0.71% | 1.21% | 1.02% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.0% | 0.0% | 0.41% |
| DII | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 1.6% | 1.59% | 1.59% | 1.3% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Healthcare — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Qms Medical Allied S Ltd (this stock) | 336 | 31.3 | 3.23 | 10.4% |
| Lyka Labs Ltd. | 328 | — | 3.39 | -10.2% |
| Ambalal Sarabhai Ent L | 304 | 19.6 | 1.86 | 12.4% |
| Nureca Limited | 293 | 61.4 | 1.56 | 1.12% |
| Medicamen Biotech Limited | 407 | 35.2 | 1.39 | 3.95% |
| Brooks Lab Limited | 203 | 58.7 | 1.08 | 22.0% |
| Bilcare Ltd. | 202 | 5.55 | 1.13 | 1.39% |
Which Mutual Funds Hold Qms Medical Allied S Ltd?
Frequently Asked Questions about Qms Medical Allied S Ltd
Qms Medical Allied S Ltd (QMSMEDI) closed at ₹170.99 on NSE on 19 November 2026, up 0.98 (0.58%) from the previous close.
Qms Medical Allied S Ltd trades on the NSE (National Stock Exchange of India) under the symbol QMSMEDI.
Qms Medical Allied S Ltd has a trailing twelve-month P/E (price-to-earnings) ratio of 31.3.
Qms Medical Allied S Ltd has a dividend yield of 0.29%.
Qms Medical Allied S Ltd's 52-week high is ₹217.0 and its 52-week low is ₹69.0.
Qms Medical Allied S Ltd has a market capitalisation of ₹336 crore.
Qms Medical Allied S Ltd has a TopFund Quality Score of 55/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Qms Medical Allied S Ltd?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.